Novocure
Tania Chander is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as Senior Vice President of Product and Portfolio Strategy at Novocure since December 2018. Tania has held multiple senior leadership roles at Novocure, including Senior Vice President of the US Business Unit Lead and Senior Vice President of Global Clinical Operations. Prior to Novocure, Tania served as Senior Vice President of Portfolio Management at Curis and held various leadership positions at MedImmune, including Associate Director in Product Development Team Leadership Oncology. Tania began their career at Bristol-Myers Squibb as a Manager in Virology Medical Strategy and also completed a Post-Doctoral Fellowship in Medical Affairs Oncology at BMS/Rutgers University. Tania holds a BS and PharmD in Pharmacy from Rutgers University.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.